Shopping Cart
- Remove All
- Your shopping cart is currently empty
Volagidemab (AMG-477) is a glucagon receptor (GCGR) antagonist and monoclonal antibody for the study of endocrine and metabolic diseases such as type 1 diabetes (T1D) and hypoglycemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $293 | In Stock | |
5 mg | $723 | In Stock | |
10 mg | $986 | In Stock | |
25 mg | $1,490 | In Stock | |
50 mg | $1,970 | In Stock |
Description | Volagidemab (AMG-477) is a glucagon receptor (GCGR) antagonist and monoclonal antibody for the study of endocrine and metabolic diseases such as type 1 diabetes (T1D) and hypoglycemia. |
In vivo | Subcutaneous injection of 5 mg/kg Volagidemab suppresses the phenotype of type 1 diabetes in a mouse model of tetracycline-induced diabetes. [2] |
Alias | REMD-477, REMD477, AMG-477, AMG477 |
Cas No. | 1233956-13-2 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.